177 related articles for article (PubMed ID: 2435806)
1. In vitro B-lymphocyte antigen priming against both non-immunogenic and immunogenic molecules requiring low amounts of antigen and applicable in hybridoma technology.
Brams P; Pettijohn DE; Brown M; Olsson L
J Immunol Methods; 1987 Apr; 98(1):11-22. PubMed ID: 2435806
[TBL] [Abstract][Full Text] [Related]
2. Human monoclonal anti-keyhole limpet hemocyanin antibody-secreting hybridoma produced from peripheral blood B lymphocytes of a keyhole limpet hemocyanin-immune individual.
Lane HC; Shelhamer JH; Mostowski HS; Fauci AS
J Exp Med; 1982 Jan; 155(1):333-8. PubMed ID: 6976416
[TBL] [Abstract][Full Text] [Related]
3. Epitope-specific regulation. I. Carrier-specific induction of suppression for IgG anti-hapten antibody responses.
Herzenberg LA; Tokuhisa T
J Exp Med; 1982 Jun; 155(6):1730-40. PubMed ID: 6176665
[TBL] [Abstract][Full Text] [Related]
4. In vitro stimulation prior to fusion generates antigen-binding human-human hybridomas.
Wasserman RL; Budens RD; Thaxton ES
J Immunol Methods; 1986 Nov; 93(2):275-83. PubMed ID: 3534099
[TBL] [Abstract][Full Text] [Related]
5. Clonal analysis of antigen-specific interactions between T cells and genetically engineered B cells.
Kitagami K; Hozumi N; Ochi A
Cell Immunol; 1987 Sep; 108(2):438-51. PubMed ID: 2957069
[TBL] [Abstract][Full Text] [Related]
6. Requirements for the generation of memory B cells in vivo and their subsequent activation in vitro for the production of antigen-specific hybridomas.
De Boer M; Ten Voorde GH; Ossendorp FA; Van Duijn G; Tager JM
J Immunol Methods; 1988 Oct; 113(1):143-9. PubMed ID: 2459251
[TBL] [Abstract][Full Text] [Related]
7. Immunization in vitro and production of monoclonal antibodies specific to insoluble and weakly immunogenic proteins.
Van Ness J; Laemmli UK; Pettijohn DE
Proc Natl Acad Sci U S A; 1984 Dec; 81(24):7897-901. PubMed ID: 6083563
[TBL] [Abstract][Full Text] [Related]
8. Antigen-based immunofluorescence analysis of B-cell targeting: advanced technology for the generation of novel monoclonal antibodies with high efficiency and selectivity.
Tomita M; Fukuda T; Ozu A; Kimura K; Tsong TY; Yoshimura T
Hybridoma (Larchmt); 2006 Oct; 25(5):283-92. PubMed ID: 17044784
[TBL] [Abstract][Full Text] [Related]
9. Dependence of T-cell-replacing factor and immunogenic dose for the production of monoclonal antibodies using the in vitro immunization technique.
Borrebaeck CA
Mol Immunol; 1984 Oct; 21(10):841-5. PubMed ID: 6334231
[TBL] [Abstract][Full Text] [Related]
10. The in vivo elimination of CD4+ T cells prevents the induction but not the expression of carrier-induced epitopic suppression.
Leclerc C; Schutze MP; Deriaud E; Przewlocki G
J Immunol; 1990 Sep; 145(5):1343-9. PubMed ID: 1696595
[TBL] [Abstract][Full Text] [Related]
11. Antigen-specific and nonspecific mediatiors of T cell/B cell cooperation. II. Two helper T cells distinguished by their antigen sensitivities.
Marrack P; Kappler JW
J Immunol; 1976 May; 116(5):1373-8. PubMed ID: 58030
[TBL] [Abstract][Full Text] [Related]
12. Increased production of antigen-specific B lymphocytes during in vitro immunization using carrier-specific T helper hybridomas.
Schilizzi BM; Kroesen BJ; The TH; de Leij L
J Immunol Methods; 1992 Aug; 153(1-2):49-56. PubMed ID: 1387673
[TBL] [Abstract][Full Text] [Related]
13. B-T lymphocyte interactions in experimental autoimmune myasthenia gravis: antigen presentation by rat/mouse hybridoma lines secreting monoclonal antibodies against the nicotinic acetylcholine receptor.
Zhang YP; Tzartos SJ; Wekerle H
Eur J Immunol; 1988 Feb; 18(2):211-8. PubMed ID: 2450756
[TBL] [Abstract][Full Text] [Related]
14. Effect of age on the expressed B cell repertoire: role of B cell subsets.
Hu A; Ehleiter D; Ben-Yehuda A; Schwab R; Russo C; Szabo P; Weksler ME
Int Immunol; 1993 Sep; 5(9):1035-9. PubMed ID: 7694639
[TBL] [Abstract][Full Text] [Related]
15. The action of interleukin-4 on antigen-specific IgG1 and IgE production by interaction of in vivo primed B cells and carrier-specific cloned Th2 cells.
Ueda A; Chandswang N; Ovary Z
Cell Immunol; 1990 Jun; 128(1):31-40. PubMed ID: 2140534
[TBL] [Abstract][Full Text] [Related]
16. Acceptor-suppressor T cell hybridoma with a receptor recognizing antigen-specific suppressor factor.
Takei I; Sumida T; Taniguchi M
J Exp Med; 1983 Dec; 158(6):1912-23. PubMed ID: 6196434
[TBL] [Abstract][Full Text] [Related]
17. Rescue of human monoclonal antibody production from an EBV-transformed B cell line by fusion to a human-mouse hybridoma.
Foung SK; Perkins S; Raubitschek A; Larrick J; Lizak G; Fishwild D; Engleman EG; Grumet FC
J Immunol Methods; 1984 May; 70(1):83-90. PubMed ID: 6201562
[TBL] [Abstract][Full Text] [Related]
18. In vivo CD40-gp39 interactions are essential for thymus-dependent humoral immunity. I. In vivo expression of CD40 ligand, cytokines, and antibody production delineates sites of cognate T-B cell interactions.
Van den Eertwegh AJ; Noelle RJ; Roy M; Shepherd DM; Aruffo A; Ledbetter JA; Boersma WJ; Claassen E
J Exp Med; 1993 Nov; 178(5):1555-65. PubMed ID: 7693849
[TBL] [Abstract][Full Text] [Related]
19. Use of particulate antigen to enhance primary in vitro antibody responses to trinitrophenyl-keyhole limpet hemocyanin.
Buttke TM; Pourbohloul S; Miller NW
J Immunol Methods; 1986 May; 89(2):233-8. PubMed ID: 3517178
[TBL] [Abstract][Full Text] [Related]
20. Effect of the elapsed time after the final antigen boost on the specificity of monoclonal antibodies produced by B cell hybridomas.
Bazin R; Lemieux R
J Immunol Methods; 1988 Aug; 112(1):53-6. PubMed ID: 3261313
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
